VINS Bioproducts completes Phase 2 clinical trials of COVID antidote VINCOV-19 Ruchika Sharma13 Oct 2022 11:15 AM ISTHyderabad: VINS Bioproducts Limited, an immunological company, based in Hyderabad, in collaboration with the Centre for Cellular and...
Johnson and Johnson gets CDSCO panel nod to study Paliperidone Palmitate Roshni Dhar1 Oct 2022 5:53 PM ISTPharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee SEC functional under Central Drug Standard Control...
Health Bulletin 30/September/2022 Roshni Dhar30 Sept 2022 5:34 PM ISTHere are the top health news for the day:Delhi: Safdarjung Hospital to ban 3-wheelerIn an order to curb pollution, Safdarjung Hospital is going to ban...
Immunotherapy before targeted therapy significantly improves advanced melanoma survival Isra Zaman28 Sept 2022 9:45 AM ISTA clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall...
CDSCO panel opines Paraxel to study either CKD or heart failure in phase IIb trial of AZD9977,Dapagliflozin FDC Susmita Roy25 Sept 2022 1:28 PM ISTNew Delhi: In line with Paraxel's clinical trial protocol to study efficacy and safety of AZD9977 in combination with dapagliflozin in patients with...
CDSCO panel tells Glenmark to submit complete clinical trial report on antidiabetic FDC Drug Dr. Nandita Mohan24 Sept 2022 5:43 PM ISTIn response to drug major Glenmark proposal to manufacture and market the antidiabetic fixed dose combination Lobeglitazone Sulphate 0.5/0.5mg plus...
Health Bulletin 24/September/2022 Dr. Nandita Mohan24 Sept 2022 5:17 PM ISTHere are the top health news for the day:Submit complete CT Report: CDSCO tells Glenmark on antidiabetic FDC drugIn response to drug major Glenmark...
Submit complete CT Report :CDSCO Tells Glenmark on antidiabetic FDC drug Dr. Divya Colin23 Sept 2022 6:00 PM ISTNew Delhi: In response to drug major Glenmark proposal to manufacture and market the antidiabetic fixed dose combination Lobeglitazone Sulphate...
Pfizer begins Phase 3 clinical trial of mRNA-based Influenza vaccine Ruchika Sharma15 Sept 2022 11:00 AM ISTNew York: Pfizer Inc. has announced that the first participants have been dosed in a pivotal Phase 3 clinical trial to evaluate the...
Conduct Phase II CT : CDSCO panel opines Zydus Pharma over Hepatitis E Vaccine Dr. Divya Colin14 Sept 2022 6:00 PM ISTNew Delhi: The Subject Expert Committee(SEC) functional under the Central Drug Standard Control Organization(CDSCO) has opined the pharma major Zydus...
Zydus Lifecsciences begins Desidustat Phase IV trial in patients with CKD induced anemia Ruchika Sharma31 Aug 2022 12:30 PM ISTDesidustat is currently approved in India as Oxemia for the treatment of anemia in Chronic Kidney Disease (CKD) patients.
Medical Bulletin 19/August/2022 Isra Zaman19 Aug 2022 3:35 PM ISTHere is the top medical news for the day:Covid out Clinical TrialPublished in the New England Journal of Medicine, researchers — led by the University...
